{"agency": "Health and Human Sevices", "agency_short": "HHS", "published": "2022-06-01T00:00:00", "title": "AO 20-02", "url": "https://oig.hhs.gov/compliance/advisory-opinions/20-02/", "attachments": [{"title": "Advisory Opinion 20-02", "url": "https://oig.hhs.gov/documents/advisory-opinions/765/AO-20-02.pdf", "mimetype": "application/pdf"}, {"title": "Modification of Advisory Opinion 20-02", "url": "https://oig.hhs.gov/documents/advisory-opinions/1035/Modification-AO-20-02.pdf", "mimetype": "application/pdf"}], "classification": "advisory-opinion", "identifier": "HHS-OIG-AO-20-02", "subagency": "Office of the Inspector General", "summary": "Regarding financial assistance for travel, lodging, and other expenses provided by a pharmaceutical manufacturer to certain patients prescribed the manufacturer's drug."}